Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
19.34
+0.68 (3.64%)
Dec 20, 2024, 4:00 PM EST - Market closed
Forte Biosciences Employees
Forte Biosciences had 9 employees as of December 31, 2023. The number of employees increased by 3 or 50.00% compared to the previous year.
Employees
9
Change (1Y)
3
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$3,799,444
Market Cap
28.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9 | 3 | 50.00% |
| Dec 31, 2022 | 6 | 1 | 20.00% |
| Dec 31, 2021 | 5 | -4 | -44.44% |
| Dec 31, 2020 | 9 | 8 | 800.00% |
| Dec 31, 2019 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| RAPT Therapeutics | 131 |
| Adagio Medical Holdings | 85 |
| NextCure | 82 |
| DURECT | 58 |
| KALA BIO | 43 |
| Calidi Biotherapeutics | 41 |
| Cognition Therapeutics | 28 |
| BriaCell Therapeutics | 16 |
FBRX News
- 26 days ago - Forte Biosciences to Host R&D Day December 3, 2024 - Business Wire
- 4 weeks ago - Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications - Business Wire
- 5 weeks ago - Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update - Business Wire
- 4 months ago - Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update - Business Wire
- 7 months ago - Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - Business Wire
- 7 months ago - Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update - Business Wire
- 9 months ago - Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update - Business Wire
- 1 year ago - Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - Business Wire